Site içinde arama yapın

Pooja Chincholkar bir ses eklendi Party
2026-07-13 07:13:10 -

Parkinson’s Disorder Drugs Market Overview: Trends, Challenges, and Forecast 2025 –2032
According to the latest report published by Data Bridge Market Research, the Parkinson’s Disorder Drugs Market CAGR Value The global Parkinson’s disorder drugs market size was valued at USD 5.19 billion in 2024 and is expected to reach USD 13.70 billion by 2032, at a CAGR of 12.90% during the forecast period Parkinson’s...

0 Yorumlar 0 hisse senetleri 50 Views 0 önizleme

Please log in to like, share and comment!
Aishwarya Chavan bir ses eklendi Party
2025-12-05 15:43:52 -

Wolff Parkinson White Syndrome MarketTrends Report: Size, Segments, Growth & Forecast Overview
The Global Wolff–Parkinson–White (WPW) Syndrome Market is gaining traction as advancements in cardiovascular diagnostics and treatment technologies continue to enhance patient outcomes. WPW syndrome, a congenital heart condition characterized by abnormal electrical pathways leading to episodes of rapid heart rate (tachycardia), affects a significant number of individuals...

0 Yorumlar 0 hisse senetleri 881 Views 0 önizleme

Please log in to like, share and comment!
Nikita Girmal bir ses eklendi Other
2026-02-11 06:33:36 -

Parkinson’s Disease Therapeutics Market to Hit USD 10.12 Billion by 2032
“According to a new report published by Introspective Market Research, Parkinson’s Disease Therapeutics Market by Drug Class, Treatment Type, and Distribution Channel, The Global Parkinson’s Disease Therapeutics Market Size Was Valued at USD 5.46 Billion in 2023 and is Projected to Reach USD 10.12 Billion by 2032, Growing at a CAGR of 7.1% From 2024–2032.” The...

0 Yorumlar 0 hisse senetleri 693 Views 0 önizleme

Please log in to like, share and comment!
Subhayan Mayra bir ses eklendi Other
2026-05-06 13:05:25 -

Global Neuroprotective Agents Market Growing at 7.1% CAGR Through 2034
According to a new report from Intel Market Research, the global Neuroprotective Agents Market was valued at USD 5.8 billion in 2025 and is projected to grow from USD 6.3 billion in 2026 to USD 10.9 billion by 2034, exhibiting a robust CAGR of 7.1% during the forecast period (2026–2034). This growth is propelled by the escalating burden of neurodegenerative diseases, a rapidly aging...

0 Yorumlar 0 hisse senetleri 297 Views 0 önizleme

Please log in to like, share and comment!